Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2023

Jan 19, 2023

32106_dirs_2023-01-18_2b452862-b739-402f-ab5b-bee86ec70086.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2023-01-03

Reporting Person: DuRoss Amy (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-01-03 Common Stock A 10187 Acquired 28344 Direct

Footnotes

F1: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and fully vests on the first anniversary of the grant date.